Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast
Shares of Eli Lilly ( NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for ...
These Stocks Are Moving the Most Today: Palantir, Nvidia, Eli Lilly, KB Home, Signet, Applied Digital, Aehr, and More
Palantir stock rebounds, sales of Eli Lilly’s blockbuster GLP-1 medicines miss estimates, and KB Home stock jumps after the ...
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...
Lilly Shares on Track for Worst Day Since 2021 After Downbeat Zepbound Sales Forecast
The company's shares were trading at $740.80, on track for their worst single-day decline in nearly four years. Lilly's stock ...
Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%
The company expects Q4 2024 revenue of approximately $13.5 billion. The updated revenue guidance is $400 million lower than ...
Insider Monkey8h
Why Eli Lilly (LLY) Stock Is Declining Today
The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced ...
Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 billion
Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to ...
6LLY : Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5...
Eli Lilly expects 2024 revenue of $45.0 billion, reflecting a 32% increase, with strong contributions from Mounjaro and ...
Business Insider10h
Eli Lilly sees growth in 2025 from new medicines
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on LLY: Eli Lilly NewsMORE ...